Erlotinib vs Trastuzumab Deruxtecan

Erlotinib vs Trastuzumab Deruxtecan: Overview

This comparison examines the pharmacological differences between Erlotinib and Trastuzumab Deruxtecan.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Pharmacokinetics

Half-life: Erlotinib — 36 hours.

Chemical Properties

Molecular Formula: Erlotinib — C22H23N3O4.

Molecular Weight: Erlotinib — 393.4380 g/mol.

Type: Erlotinib — Small molecule; Trastuzumab Deruxtecan — Antibody drug conjugate.